Royalty Pharma plcRPRXNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank100
3Y CAGR+2.1%
5Y CAGR+2.3%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+2.1%/yr
vs +5.7%/yr prior
5Y CAGR
+2.3%/yr
Consistent
Acceleration
-3.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.38B | +5.1% |
| 2024 | $2.26B | -3.9% |
| 2023 | $2.35B | +5.2% |
| 2022 | $2.24B | -2.3% |
| 2021 | $2.29B | +7.9% |
| 2020 | $2.12B | +17.0% |
| 2019 | $1.81B | +1.1% |
| 2018 | $1.79B | +12.3% |
| 2017 | $1.60B | -14.9% |
| 2016 | $1.88B | - |